title: Washout rate of cardiac iodine-123 metaiodobenzylguanidine is high in chronic heart failure patients with central sleep apnea.
abstract: BACKGROUND
  The association between sleep-disordered breathing (SDB) assessed by polysomnography and cardiac sympathetic nerve activity (SNA) assessed by cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) imaging has not been investigated in patients with chronic heart failure (CHF).
  
  
  RESULTS
  We performed cardiac 123I-MIBG scintigraphy and overnight polysomnography in 59 patients with stable CHF. The patients were classified into the 3 groups: 19 with no or mild SDB (NM-SDB, apnea-hypopnea index <15); 21 with central sleep apnea (CSA), and 19 with obstructive sleep apnea (OSA). The cardiac washout rate (WR) of 123I-MIBG was obtained from initial and delayed planar 123I-MIBG images. The WR was higher in patients with CSA (54.2 + or - 11.6%) than in those with OSA (37.9 + or - 8.6%, P < .05) or NM-SDB (40.8 + or - 8.8%, P < .05). The WR correlated positively with central apnea index (rho = 0.40, P = .002). A stepwise multiple regression analysis selected CSA and plasma brain natriuretic peptide levels as independent variables associated with the WR.
  
  
  CONCLUSIONS
  The WR was higher in CHF patients with CSA than in those with OSA or NM-SDB, and CSA was independently associated with the WR, suggesting a link of CSA to increased cardiac SNA in CHF.
authors.affiliation: Internal Medicine 2, Faculty of Medicine, Oita University, Yufu, Japan. akira@med.oita-u.ac.jp
authors.forename: Akira
authors.initials: A
authors.lastname: Tamura
authors.forename: Shinichi
authors.initials: S
authors.lastname: Ando
authors.forename: Yukie
authors.initials: Y
authors.lastname: Goto
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Kawano
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Shinozaki
authors.forename: Munenori
authors.initials: M
authors.lastname: Kotoku
authors.forename: Junichi
authors.initials: J
authors.lastname: Kadota
mesh_terms: D019797:3-Iodobenzylguanidine; D000368:Aged; D005260:Female; D006305:Health Status Indicators; D006333:Heart Failure / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D020097:Natriuretic Peptide, Brain / Q000097:blood; D017286:Polysomnography; D011379:Prognosis; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012044:Regression Analysis; D020182:Sleep Apnea, Central / Q000503:physiopathology*; D018709:Statistics, Nonparametric; D013318:Stroke Volume; D013564:Sympathetic Nervous System; D016277:Ventricular Function, Left
chemical_list: D019275:Radiopharmaceuticals; D020097:Natriuretic Peptide, Brain; D019797:3-Iodobenzylguanidine